Kenso Agcare Atrazine 900 WG Herbicide

Hazard statements (CLP)

H317, H373, H410

Code

Statements

H317

May cause an allergic skin reaction

H373

May cause damage to organs through prolonged or repeated exposure

H410

Very toxic to aquatic life with long lasting effects

2.1 Classification of the substance or mixture

Classified as hazardous according to criteria of Safe Work Australia. Not classified as a Dangerous Good according to the ADG Code.

Signal word

WARNING

Hazard statements

H317: May cause an allergic skin reaction. H373: May cause damage to organs through prolonged or repeated exposure. H410: Very toxic to aquatic life.

Prevention

P260: Do not breathe dust/fume/gas/mist/vapours/spray. P261: Avoid breathing fumes, mists, vapours or spray. P272: Contaminated work clothing should not be allowed out of the workplace. P273: Avoid release to the environment. P280: Wear protective gloves, protective clothing and eye or face protection.

Response

P302 + P352 IF ON SKIN Wash with plenty of soap and water P304 + P340 IF INHALED Remove victim to fresh air and keep at rest in a position comfortable for breathing. P311: Call a POISON CENTRE or doctor/ physician. P333 + P313 If skin irritation or rash occurs Get medical advice/ attention. P314: Get medical advice/attention if you feel unwell. P363: Wash contaminated clothing before reuse. P391: Collect spillage.

Disposal

P501: Dispose of contents and containers as specified on the registered label.

SUSMP Classification

S5

ADG classification

Not a dangerous good.

UN Number

N/A Emergency Overview Physical Description & colour: Off-white water dispersible granules. Odour: Non specific odour

Health hazards

No major health hazard is known

Potential health effects

Acute: Swallowed: low toxicity, if swallowed. Oral LD50 (rats) > 2200 mg/kg. Dermal absorption: Low toxicity. Tests on rats using atrazine technical indicate a low toxicity due to skin contact with undiluted product. (LD50 > 3100 mg/kg, for active ingredient) Eye: Slightly irritating. (rabbits) Skin: Slightly irritating. (rabbits) Inhaled: Low toxicity. Tests on rats with comparable 900 WG formulation indicate a low toxicity due to inhalation of undiluted product. (LC50 (4h), active ingredient > 710 mg/m3, no toxic concentration attainable) Chronic: (Active Ingredient) Atrazine technical has been extensively tested on laboratory mammals and in test-tube systems. No evidence of mutagenic, teratogenic or reproductive effects was obtained. After long-term administration (ie, close to 2 years of continuous feeding) a slight increase in the incidence of mammary tumours was reported in one species (rat), one sex (female) and one strain (Sprague- Dawley) in one study at higher doses. A more recent study (1992) using Sprague-Dawley rats showed no significant difference between rats fed normal diet and those fed on a diet containing atrazine with regard to the incidence of tumours. Recent studies with the Fischer rat strain have shown no evidence of tumour producing potential. The relevance of the mammary tumour finding to humans is doubted as epidemiological studies of workers involved in the production of atrazine for up to 30 years have shown no evidence of health problems associated with atrazine exposure. Atrazine has been listed by IARC as a Class 3, not classifiable as to carcinogenicity to humans.